Skip to main content
. 2005 Mar;59(3):281–290. doi: 10.1111/j.1365-2125.2004.02253.x

Figure 3.

Figure 3

Simulated peak anti-Xa concentrations at 7 days vs. GFR for patients with a distribution of renal function recruited in the study using the standard dose of 1.0 mg kg−1 body weight. The upper, middle and lower lines represent the 90th, 50th and 10th percentiles, respectively